High affinity interactions of coxsackievirus A9 with integrin αvβ3 (CD51/61) require the CYDMKTTC sequence of β3, but do not require the RGD sequence of the CAV-9 VP1 protein

Human Immunology

Volumn 61, Issue 5, 2000, Pages 453-459

  Triantafilou, Martha ^a   Triantafilou, Kathy ^a   Wilson, Keith M ^a   Takada, Yoshikazu ^b   Fernandez, Nelson ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

3; CAV 9; CD51 61; RGD

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CAPSID PROTEIN; INTEGRIN; MONOCLONAL ANTIBODY; VIRUS RECEPTOR; VITRONECTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHO CELL; CONTROLLED STUDY; COXSACKIE VIRUS A; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; RNA VIRUS; STRUCTURE ANALYSIS; VIRUS ADSORPTION;

AMINO ACID SEQUENCE; ANTIGENS, CD; CAPSID; CAPSID PROTEINS; ENTEROVIRUS; INTEGRIN ALPHAV; INTEGRIN BETA3; OLIGOPEPTIDES; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN BINDING;

EID: 0034050359     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00103-8     Document Type: Article

References (42)

1. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion RGD and integrins . Science. 238:1987;491.
2. Ruoslahti E. Integrins. J Clin Invest. 87:1991;1.
3. Hynes R.O. Integrins versality, modulation, and signaling in cell adhesion . Cell. 69:1992;11.
4. Corbi A.L., Miller L.J., O'Connor K., Larson R.S., Springer T.A. cDNA cloning and complete primary structure of the alpha-subunit of a leukocyte adhesion glycoprotein, P150,95. EMBO J. 6:1987;4023.
5. Corbi A.L., Kishimoto T.K., Miller L.J., Springer T.A. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem. 263:1988;12403.
6. Larson R.S., Corbi A.L., Berman L., Springer T. Primary structure of the leukocyte function associated molecule-1 alpha-subunit, an integrin with an embedded domain defining a protein superfamily. J Cell Biol. 108:1989;703.
7. Verweij C.L., Diergaarde P.J., Hart M., Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J. 5:1986;1839.
8. Bonaldo P., Russo V., Bucciotti F., Bressan G.M., Colombatti A. Alpha 1 chain of chick type VI collagen. The complete cDNA sequence reveals a hybrid molecule made of one short collagen and three von Willebrand factor type A-like domains. J Biol Chem. 264:1989;5575.
9. Chu M.L., Zhang R.Z., Pan T.C., Stokes D., Conway D., Kuo H.J., Glanville R., Mayer U., Mann K., Deutzmann R., Timple R. Mosaic structure of globular domains in the human type VI collagen alpha 3 chain similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors . EMBO J. 9:1990;385.
10. Mole J.E., Anderson J.K., Davison E.A., Woods D.E. Complete primary structure for the zymogen of human-complement factor-B. J Biol Chem. 259:1984;3407.
11. Landis R.C., Bennett R.I., Hogg N. A novel LFA-1 activation epitope MAPS to the I-domain. J Cell Biol. 120:1993;1519.
12. Diamond M.S., Garciaaguilar J., Bickford J.K., Corbi A.L., Springer T.A. The I-domain is a major recognition site on the leukocyte integrin MAC-1 (CD11B/CD18) for 4 distinct adhesion ligands. J Cell Biol. 120:1993;1031.
13. Ueda T., Rieu P., Brayer J., Arnaout M.A. Identification of the complement IC3B binding-site in the beta-2 integrin CR3 (CD11B/CD18). Proc Natl Acad Sci USA. 91:1994;10680.
14. Muchowski P.J., Zhang L., Chang E.R., Soule H.R., Plow E.F., Moyle M. Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I-domain of CD11b/CD18. J Biol Chem. 269:1994;26419.
15. Kamata T., Wright R., Takada Y. Critical threonine and aspartic acid residues within the I domains of β2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem. 270:1995;12531.
16. Lee J.O., Rieu P., Arnaout M.A., Liddington R. Crystal-structure of the A-domain from the A-subunit of integrin CR3 (CD11B/CD18). Cell. 80:1995;631.
17. Puzon-McLaughlin W., Takada Y. Critical residues for ligand binding in an I domain-like structure of the integrin β1 subunit. J Biol Chem. 271:1996;20438.
18. Goodman T.G., Bajt M.L. Identifying the putative metal ion-dependent adhesion site in the beta (2) (CD18) subunit required for alpha (L)beta (2) and alpha (M) beta(2) ligand interactions. J Biol Chem. 271:1996;23729.
19. Tozer E.C., Liddington R.C., Sutcliffe M.J., Smeeton A.H., Loftus J.C. Ligand binding to integrin alpha(IIb)beta(3) is dependent on a MIDAS-like domain in the beta(3) subunit. J Biol Chem. 271:1996;21978.
20. Takagi J., Kamata T., Meredith J., Puzon-McLaughlin W., Takada Y. Changing ligand specificities of αvβ1 and αvβ3 integrins by swapping a short diverse sequence of the β subunit. J Biol Chem. 272:1997;19794.
21. Yokoyoma K., Zhang X., Medved L., Takada Y. Specific binding of integrin αvβ3 to the fibrinogen γ and αE chain C-terminal domains. Biochemistry. 38:1999;5872.
22. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins αvβ3 and αvβ5 promote adenovirus internalisation but not virus attachment. Cell. 73:1993;309.
23. Mason P.W., Rieder E., Baxt B. RGD sequence of FMDV is essential for infecting cells via the natural receptor, but can be bypassed by an antibody-dependent enhancement pathway. Proc Nat Acad Sci USA. 91:1994;1932.
24. Berinstein A., Roivainen M., Hovi T., Mason P.W., Baxt B. Antibodies to the vitronectin receptor (integrin αvβ3) inhibit binding and infection of foot and mouth disease virus to cultured cells. J Virol. 69:1995;2664.
25. Hernandez J., Valero M.L., Andreu D., Domingo E., Mateu M.G. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif a structural interpretation . J Gen Virol. 77:1996;257.
26. Mateu M.G., Valero M.L., Andreu D., Domingo E. Systematic replacement of aminoacid residues within the Arg-Gly-Asp, containing loop of foot and mouth disease virus and effect on cell recognition. J Biol Chem. 271:1996;12814.
27. Neff S., Sa-Carvalho D., Rieder E., Mason P.W., Blystone S.D., Brown E.J., Baxt B. Foot and mouth disease virus virulent for cattle utilizes the integrin αvβ3 as its receptor. J Virol. 72:1998;3587.
28. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T. Entry of Coxsackievirus A9 into host cells specific interactions with αvβ3 integrin, the vitronectin receptor . Virology. 203:1994;357.
29. Roivainen M., Hyypiä T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. RGD-dependent entry of Coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol. 65:1991;4735.
30. Roivainen M., Piirainen L., Hovi T. Efficient RGD independent entry of Coxsackievirus A9. Arch Virol. 141:1996;1909.
31. Hughes P.J., Horsnell C., Hyypiä T., Stanway G. The Coxsackievirus A9 RGD motif is not essential for virus viability. J Virol. 69:1995;8035.
32. Cheresh D.A., Spiro R.C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 262:1987;17703.
33. vβ3 molecules in the Coxsackievirus A9 infectious cycle. J Gen Virol. 80:1999;2591.
34. Ward T., Powell R.M., Pipkin P.J., Evans D.J., Minor P.D., Almond J.W. Role of β2 microglobulin in Echovirus infection of rhabdomyosarcoma cells. J Virol. 72:1998;5360.
35. Horton M.A. The αvβ3 integrin. Vitronectin receptor. Int J Biochem Cell Biol. 29:1997;721.
36. Smith J.W., Hu D., Satterthwait A., Pinz-Sweeney S., Barbas C.F. III. Building synthetic antibodies as adhesive ligands for integrins. J Biol Chem. 269:1994;32788.
37. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular enrty of Hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J Virol. 73:1999;3951.
38. Baxt B., Becker Y. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsoption of foot and mouth disease virus to tissue culture cells. Virus Genes. 4:1990;73.
39. Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D., Brown F. The cell attachment site on foot and mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol. 70:1989;625.
40. 1K affect virus attachment to target cells. J Virol. 71:1997;1046.
41. McKenna T.S., Lubroth J., Rieder E., Baxt B., Mason P.W. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol. 69:1995;5787.
42. Martinez M.A., Verdaguer N., Mateu M.G., Domingo E. Evolution subverting essentiality dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus . Proc Natl Acad Sci USA. 94:1997;6798.